Digital biomarker company Koneksa has launched the first collaboration in the Koneska Academic Partnership Program for Parkinsonâs Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs.
Koneksa is a New York-based digital biomarker platform that offers solutions such as patient-generated data capturing, monitoring and analysis for the healthcare sector.